AR226-2086 w m m mRobert F Ptnchot 09/20/99 08:27 AM To: Anthony J Playtis/CUDuPont@DuPont, Robin C Leonard/AE/DuPont@DuPont, Roger J 2ipfel/AE/DuPont@DuPont cc: Subject: C-8 testing at Spruance .

Does not contain TSCACBI AR226-3329 DuPont Fluorotelomer Supply Chain Update Presented to Supply Chain Team 3 December 2004 Contains CBI - DuPont Confidential Surface Protection Solutions Company SanWzed.

AR226-2175 Chris E Shoop 08/08/2001 05:23 PM To: cc: Subject: Debbie J Mulrooney/AE/DuPont@DuPont Robert L Ritchey/CL/DuPont@DuPont, M.

Rob __________________ Forwarded by Robert F Pinchot/DEV/AE/DuPont on 01/15/2002 03:26 PM Debbie J Mulrooney " 01/15/2002 03:21 PM To: Robert F Pinchot/DEV/AE/DuPont@DuPont cc: Subject: Model Results Rob, The attached spreadsheet shows the vapor concentrations at the fo u r specific receptor locations.

AR226-2175 Chris E S h o op 08/08/2001 05:23 PM _____________________________ To: Debbie J Mulrooney/AE/DuPont@DuPont cc: Robert L Ritchey/CL/DuPont@DuPont, M.

0004 ("Tii mm AR&S.G- Anthony J Flaylis 08/08/2000 12:36 PM To: Gary W Jepson/AE/DuPont@DuPont co: Robin C Leonard/AE/DuPont@DuPont, RobertF Pinchot/DEV/AE/DuPont@Dl/Pont Subject Pensioner Blood Data Gary, C-8Here are the results for in blood tor all pensioners who were tested in both 1995 and 2000.

Korziniowski - DuPont RECEIVED OPPT NCIC 2003 OCT-15 AM 8:10

AR226-2486 David M Rurak 09/06/2002 01:11 PM To: Robert F Pinchot/DEV/AE/DuPont@DuPont cc: Subject: Environmental coordination -- Forw arded by David M R urak/AE/DuPont on 0 9/0 6/20 0 2 01:10 PM - f Uma Chowdhry ' 0 8 /28 /2 0 0 2 11:16 AM To: David M Rurak/AE/DuPont@DuPont cc: Subject: Environmental coordination I hear you are the env coordinator for the C8 issue.,!

AR226-2639 28 Forwarded by Andrea V Malinowski/AE/DuPont on 11/15/2004 11:33 AM Jim E Pesek/AE/DuPont 11/15/2004 11:17 AM To Michael D Aucoin/AE/DuPont@DuPont, Andrew S Hartten/AE/DuPont@DuPont, Andrea V Malinowski/AE/DuPont@DuPont cc Jeff E Todd/HO/DuPont@DuPont, Bradley S Martin/AE/DuPont@DuPont Subject Re : data in Envista for PAS (Document link: Andrea Malinowski) Andrew and Andrea-- I now have the explanations for the data set below.

X. du Pont da Honours and Coap&ny Sponsort DuPont Chooicala B.

Communication and regulatory aspects Robert Rickard (DuPont) sid that is going to have a FYI ("For your information") `meeting with EPA next Wednesday, August 25.

AR226-3209 DuPont-2920 Supplement No. 1 TRADE SECRET Study Title H-23926: Biopersistence Screening 10-Dose Oral Gavage Study in Rats Supplement No. 1 Laboratory Project ID: DuPont-2920 Author: Carol Finlay, B.A.

Does not contain TSCA CBI H-24001: Biopersistence Screening 10-Dose Oral Gavage Stndy in Rats DuPont-2924 Supplement No. 1 LIST OF TABLES Page 1.

Frame, a veterinary pathologist at DuPont (the study pathologist for the DuPont Study).

Ellis (DuPont CRG).